EBIT: Income before interest and taxes.
ZIVO Bioscience, Inc. (ZIVO) had EBIT of $-0.94M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.95M |
|
-- |
|
-- |
|
$0.94M |
|
$-0.94M |
|
$-0.01M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
|
EBIT |
$-0.94M |
$-0.48M |
|
4.00M |
|
4.00M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$0.27M |
|
-- |
|
$0.25M |
|
$0.52M |
|
$3.76M |
|
-- |
|
$0.18M |
|
$3.94M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
4.00M |
|
| Cash Flow Statement Financials | |
$-0.21M |
|
-- |
|
$0.15M |
|
$0.07M |
|
$0.00M |
|
$-0.06M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.07 |
|
-- |
|
-- |
|
-- |
|
-0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
27.78% |
|
27.78% |
|
-184.12% |
|
27.78% |
|
$-0.86 |
|
$-0.05 |
|
$-0.05 |
|